Latest 10-Q quarterly reports

AbCellera Biologics Inc. reported its first quarter 2026 financial results, highlighting increased revenue and progress in its internal drug candidate pipeline, particularly with ABCL635.

Cadre Holdings reports a significant drop in net income for Q1 2026, largely due to increased expenses from recent acquisitions and higher interest costs, despite a substantial rise in net sales.

Turn Therapeutics reports a net loss of $0.97 million for Q1 2026, with cash reserves projected to last into Q1 2027, alongside securing a $25 million debt facility.

PACS Group, Inc. announces significant revenue growth and improved profitability in its first quarter of 2026, driven by increased patient days and occupancy rates.

ATN International's Q1 2026 results show revenue growth and reduced net loss, with progress on its significant tower portfolio sale expected in Q2.

Chegg, Inc. reported a significant year-over-year revenue decline in its Q1 2026 results, primarily driven by a sharp decrease in Academic Services, while Chegg Skilling showed modest growth.

MARA Holdings reported a decrease in Q1 2026 revenue driven by lower bitcoin prices, while advancing strategic acquisitions in AI and HPC infrastructure.

Pioneer Bancorp, Inc. announced its first quarter 2026 financial results, reporting a net income of $5.3 million, and detailing the acquisition of Targeted Lending Co., LLC.

Douglas Elliman Inc. reported a net loss of $16.3 million for the first quarter of 2026, with revenues declining 15% year-over-year due to lower brokerage commissions and the absence of property management income.

EVI Industries, Inc. announced its third-quarter fiscal year 2026 financial results, showing increased revenues driven by recent acquisitions and price adjustments, alongside improved gross margins.

FONAR Corporation's Q3 2026 Form 10-Q reveals a slight revenue increase but a decrease in net income, alongside ongoing progress in a proposed going-private transaction.

SKYX Platforms Corp. reports a 9.8% revenue increase in Q1 2026, driven by higher unit sales, while net loss widens slightly.

Amplify Energy Corp. reported a net loss of $38.1 million for the first quarter of 2026, impacted by ongoing portfolio simplification and divestitures, with a focus on its Bairoil and Beta oil and NGL producing properties.

Hims & Hers Health, Inc. reported a 4% increase in total revenue for Q1 2026, reaching $608.1 million, but experienced a significant net loss of $92.1 million.

A SPAC II Acquisition Corp. reports a net loss of $72,295 for Q1 2026, with continued focus on identifying a business combination target.

Centurion Acquisition Corp. reports net income of $2.52 million for Q1 2026, primarily from interest on trust account investments, while continuing its search for a business combination.

Forward Air Corporation reported a net loss of $34.3 million for Q1 2026, an improvement from the prior year's loss, driven by revenue shifts and expense management.

Eikon Therapeutics, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing ongoing clinical development, a significant increase in R&D expenses, and a substantial cash position post-IPO.

Perspective Therapeutics reports significant progress in its radiopharmaceutical pipeline, with strong cash reserves extending funding into late 2027, alongside a substantial capital raise.

Erasca, Inc. reported its first quarter 2026 financial results, highlighted by a significant in-process R&D expense related to a license expansion, while also disclosing a new intellectual property dispute with Revolution Medicines.

InTest Corporation announced a significant increase in revenue for the first quarter of 2026, driven by strong performance across multiple market segments.

Ceva, Inc. announced its first quarter 2026 financial results, reporting an 11% year-over-year increase in total revenues to $27.0 million, driven by a significant rise in licensing and related revenues.

Elicio Therapeutics reports a decrease in R&D expenses for Q1 2026, alongside an increase in G&A costs, and highlights ongoing concerns about its ability to continue as a going concern.

Getty Images Holdings, Inc. reported a modest 1.1% revenue increase for Q1 2026, driven by strong editorial content performance, while navigating ongoing merger discussions with Shutterstock and significant legal proceedings.

VAALCO Energy Inc. reported a net loss of $93.8 million for the first quarter of 2026, a significant shift from the prior year's profit, driven by lower revenues and substantial derivative instrument losses.

Biote Corp. reported a significant decrease in revenue and net income for Q1 2026, impacted by a product recall, increased legal expenses, and a shift in revenue streams.

Kayne Anderson BDC, Inc. disclosed its Q1 2026 financial performance, highlighting a diverse portfolio of debt and equity investments across various industries.

Franklin Financial Services Corporation reported a significant increase in net income for the first quarter of 2026, driven by robust net interest income and growth in wealth management fees.

Rekor Systems Inc. announced its first quarter 2026 financial results, showing a 12% increase in total revenue to $10.3 million, driven by growth across its product lines.

FutureFuel Corp. reported a significant revenue increase in Q1 2026 driven by its chemical segment, but also saw a widening net loss due to operational costs and derivative impacts.